Sale of 54,916 RSU shares planned at Taysha (NASDAQ: TSHA)

Rhea-AI Filing Summary

Taysha Gene Therapies (TSHA) has a planned sale of 54,916 shares of common stock under a Form 144 notice. The shares are to be sold through Maxim Group LLC on the Nasdaq, with an aggregate market value of 279,522.44 and an approximate sale date of 01/23/2026. The issuer reports 273,919,373 shares of this class outstanding.

The shares come from a restricted stock unit (RSU) award acquired on 01/23/2026, which vested and was settled in stock on the same date. The consideration for the grant was the reporting person’s continued service as an employee of the issuer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group LLC 300 Park Avenue, 16th Floor New York NY 10022	54916	279522.44	273919373	01/23/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/23/2026	RSU Award	Issuer			54916	01/23/2026	Vested grant settled in stock; consideration was Reporting Person's continued service as an employee of the Issuer.

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the TSHA Form 144 filing disclose?

The Form 144 for TSHA discloses a planned sale of 54,916 shares of common stock, with an aggregate market value of 279,522.44, to be executed through Maxim Group LLC on the Nasdaq around 01/23/2026.

How many TSHA shares are planned to be sold under this Form 144?

The notice covers a planned sale of 54,916 shares of TSHA common stock, with an indicated aggregate market value of 279,522.44.

What is the source of the TSHA shares being sold in this Form 144?

The 54,916 TSHA common shares come from an RSU award acquired on 01/23/2026, which vested and was settled in stock on that date as compensation for the reporting person’s continued service as an employee.

Which broker and exchange are involved in the TSHA Form 144 sale?

The shares are to be sold through Maxim Group LLC, with trading on the Nasdaq as the named securities exchange.

How many TSHA common shares are outstanding according to the Form 144?

The filing states that there are 273,919,373 shares of TSHA common stock outstanding for the class referenced in this notice.

What does the Form 144 say about the reporting person’s knowledge of TSHA information?

The person for whose account the securities are to be sold represents by signing that they do not know any material adverse information about TSHA’s current or prospective operations that has not been publicly disclosed.